Avid Bioservices (NASDAQ:CDMO – Free Report) had its target price lowered by Royal Bank of Canada from $17.00 to $15.00 in a research report sent to investors on Friday morning, Marketbeat.com reports. Royal Bank of Canada currently has an outperform rating on the biopharmaceutical company’s stock. Separately, Stephens decreased their target price on Avid Bioservices […]
Avid Bioservices, Inc. (NASDAQ:CDMO – Get Free Report)’s stock price reached a new 52-week low during trading on Friday after Royal Bank of Canada lowered their price target on the stock from $17.00 to $15.00. The stock traded as low as $10.08 and last traded at $10.58, with a volume of 63865 shares changing hands. […]
Independent Advisor Alliance Buys 1,500 Shares of Avid Bioservices, Inc (NASDAQ:CDMO) etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Avid Bioservices, Inc. (NASDAQ:CDMO – Free Report) insider Richard A. Richieri sold 2,758 shares of the business’s stock in a transaction that occurred on Thursday, June 29th. The stock was sold at an average price of $12.70, for a total value of $35,026.60. Following the sale, the insider now owns 17,163 shares of the company’s […]